Close
Almac
Achema middle east

Drug Research

J&J Buys Halda for $3bn to Own the Cell Death Platform

Johnson & Johnson will be paying $3.05 billion so as to acquire Halda Therapeutics, thereby getting a novel cell death platform while at the same time also strengthening its prostate cancer franchise that’s built on Erleada. At the mainstay of the...

CRISPR and Gene Editing: Next-Gen Manufacturing Impacts

The pharmaceutical and biotechnology industries are experiencing a profound technological revolution driven by CRISPR-Cas9 and emerging gene editing technologies that fundamentally alter how therapeutic agents are developed and manufactured. Gene editing pharma manufacturing represents far more than incremental improvement...

In Silico and Virtual Trials: Revolutionizing Drug Development

Drug development is entering an era of radical transformation as pharmaceutical companies embrace virtual trials and in silico methodologies to reimagine the clinical research process. These digital-first strategies tap into computational models, artificial intelligence, and patient-specific simulations to address...

Injectable Drug Delivery System Innovations

Innovations in Injectable and Parenteral Drug Delivery Systems The evolution of injectable drug delivery systems marks a transformative period in pharmaceutical therapeutics, where technological sophistication converges with patient-centered design to revolutionize how medications reach their targets. Global market valuations exceeding...

Novel Excipients for Next Generation Drug Formulation

Exploring Novel Excipients for Next Generation Drug Formulation The landscape of pharmaceutical development finds itself at a critical juncture where the complexity of drug molecules increasingly outpaces the capabilities of traditional formulation approaches. Novel excipients drug formulation represents not merely...

Advances in Lipid-Based Drug Formulations for Solubility

Advances in Lipid-Based Drug Formulation for Solubility Enhancement The pharmaceutical industry faces a persistent challenge that threatens to derail promising drug candidates before they reach patients. Poor aqueous solubility afflicts over 70% of new molecular entities in development pipelines, creating...

Nanotechnology Transforming Oral Drug Delivery

Revolutionizing Oral Drug Delivery with Nanotechnology The pharmaceutical landscape stands at a transformative juncture where nanotechnology oral drug delivery systems are reshaping how medications reach their therapeutic targets. This convergence of nanoscience and pharmaceutical formulation addresses fundamental challenges that have...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »